| |
| |
|
| Insider
Information: |
Kabakoff David S |
| Relationship: |
Director |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
115,217 |
|
|
Indirect Shares
|
503,577 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
618,794 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trius Therapeutics Inc |
TSRX |
Director |
2010-10-08 |
52,980 |
2013-09-11 |
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2011-01-28 |
0 |
Premium* |
|
|
Nextcure, Inc. |
NXTC |
Director |
2019-05-08 |
62,237 |
|
0 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2019-07-29 |
0 |
2021-06-17 |
503,577 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TSRX |
Trius Therapeutics Inc |
Director |
– • – |
2010-08-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
41,860 |
|
- |
|
| NXTC |
Nextcure, Inc. |
Director |
– • – |
2019-05-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
62,237 |
|
- |
|
| TSRX |
Trius Therapeutics Inc |
Director |
– • – |
2010-08-06 |
4 |
B |
$5.00 |
$150,000 |
I/I |
30,000 |
34,570 |
2.1 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Director |
– • – |
2010-08-06 |
4 |
A |
$0.00 |
$0 |
I/I |
9,855 |
4,570 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Director |
– • – |
2010-10-08 |
4 |
OE |
$1.29 |
$14,345 |
D/D |
11,120 |
52,980 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Director |
– • – |
2010-10-08 |
4 |
OE |
$1.29 |
$23,905 |
I/I |
18,531 |
53,101 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2011-01-28 |
4 |
OE |
$11.33 |
$745,590 |
D/D |
52,002 |
52,002 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2011-06-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
35,002 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2011-06-02 |
4 |
S |
$36.41 |
$72,819 |
D/D |
(2,000) |
50,002 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2012-06-04 |
4 |
A |
$10.10 |
$25,250 |
D/D |
2,500 |
37,502 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2013-08-30 |
4 |
S |
$14.82 |
$148,245 |
D/D |
(10,002) |
30,500 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Director |
– • – |
2013-09-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(111,366) |
0 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2014-05-29 |
4 |
S |
$39.56 |
$197,800 |
D/D |
(5,000) |
21,600 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2014-05-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
900 |
26,600 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2014-09-03 |
4 |
OE |
$9.99 |
$59,940 |
D/D |
6,000 |
27,600 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2014-09-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,500 |
24,100 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2014-09-29 |
4 |
D |
$74.00 |
$1,598,400 |
D/D |
(21,600) |
2,500 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2014-09-29 |
4 |
D |
$74.00 |
$185,000 |
D/D |
(2,500) |
0 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • • |
2019-07-29 |
4 |
B |
$16.00 |
$1,000,000 |
I/I |
62,500 |
1,833,577 |
2.25 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • • |
2019-07-29 |
4 |
S |
$16.00 |
$144 |
I/I |
(9) |
1,771,077 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • • |
2019-07-29 |
4 |
OE |
$0.02 |
$231 |
I/I |
11,572 |
1,771,086 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • • |
2019-07-29 |
4 |
A |
$0.00 |
$1,068,198 |
I/I |
1,759,514 |
1,759,514 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • • |
2020-01-28 |
4 |
AS |
$30.02 |
$750,493 |
I/I |
(25,000) |
1,808,577 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • • |
2020-01-31 |
4 |
AS |
$30.02 |
$750,388 |
I/I |
(25,000) |
1,783,577 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • • |
2020-02-03 |
4 |
AS |
$31.06 |
$776,525 |
I/I |
(25,000) |
1,758,577 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
